Harmony Price To Sales Ratio from 2010 to 2024

HRMY Stock  USD 34.67  1.08  3.02%   
Harmony Biosciences Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio will likely drop to 3.14 in 2024. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Harmony Biosciences' market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.30033853
Current Value
3.14
Quarterly Volatility
188.43776502
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Harmony Biosciences Holdings over the last few years. Price to Sales Ratio is figured by comparing Harmony Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Harmony Biosciences sales, a figure that is much harder to manipulate than other Harmony Biosciences Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Harmony Biosciences' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.99 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Harmony Price To Sales Ratio Regression Statistics

Arithmetic Mean264.40
Geometric Mean97.68
Coefficient Of Variation71.27
Mean Deviation171.63
Median393.12
Standard Deviation188.44
Sample Variance35,509
Range390
R-Value(0.82)
Mean Square Error12,508
R-Squared0.67
Significance0.0002
Slope(34.56)
Total Sum of Squares497,123

Harmony Price To Sales Ratio History

2024 3.14
2023 3.3
2022 7.45
2021 8.03
2020 12.87

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 3.30  3.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.